In our laboratory we incorporate advanced artificial intelligence tools applied to embryology, capable of analyzing microscopic images of oocytes to generate additional insights into their reproductive potential.
These technologies help both patients and specialists better understand treatment outcomes and support decision-making with more information, without adding extra procedures to the process.
Violet™ – Artificial intelligence for fertility preservation
Violet™ is an AI-based report designed for women who wish to freeze their eggs for fertility preservation.
The system analyzes images of the oocytes before vitrification and generates personalized estimates of their reproductive potential, offering a clearer understanding of future success probabilities.
The report includes:
-
Number of mature eggs frozen
-
Images of the oocytes before freezing
-
Estimated overall probability of live birth
-
Individual probability of each oocyte developing into an embryo (blastocyst day 5–6)
This analysis does not add any additional procedures and is performed using images already obtained in the laboratory during the standard process.
Its goal is to provide greater transparency and information to help plan future reproductive decisions.
When is artificial insemination recommended?
Artificial insemination is the closest treatment to conceiving naturally. The aim is to elevate the probability of pregnancy with minimal intervention focused on two aspects: concentrating the amount of sperm and reducing distance travelled to reach the egg. In this sense, fertilisation is simplified.
Artificial insemination is recommended for couples who have failed to conceive over an extended period of time. While not effective for severe cases of infertility due to not being overly interventionist, it is a recommended treatment in this intermediate field.
The premises for artificial insemination are the recipient is no older than 35-years-age, has a good ovarian reserve and a functional fallopian tube, while it is also preferable to undergo treatment as soon as sterility problems begin to persist for couples such as:
- Unknown causes (idiopathic sterility)
- Women with endometriosis
- Diagnosed polycystic ovary syndrome or further ovulation disorders
- Sexual problems such as vaginismus, impotence or retrograde ejaculation.
- Abnormalities in the cervix or lack of cervical mucus
- Poor or low-quality semen
- Homosexual female couples or single women should also consider artificial insemination using donor sperm, although if both members of a same-sex relationship want to participate in the pregnancy ROPA is recommended.
MAGENTA™ – Oocyte potential assessment in IVF/ICSI
MAGENTA™ is an artificial intelligence tool used during IVF/ICSI cycles to evaluate the potential of each retrieved oocyte.
Based on the analysis of microscopic images, the system assigns each oocyte a score from 0 to 10, indicating its probability of fertilization and development into a high-quality blastocyst (day 5–7).
The report includes:
-
Distribution of MAGENTA™ scores within the cycle
-
Record of the number of oocytes retrieved and analyzed
-
Individual images of each mature oocyte
-
Specific score assigned to each oocyte
This analysis does not require any additional procedures and is performed using images generated in the embryology laboratory.
Its purpose is to provide greater clarity and personalization during IVF treatment, helping patients better understand the potential of the retrieved oocytes.